These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6859266)

  • 1. Saturation kinetics in hepatic drug removal: a statistical approach to functional heterogeneity.
    Bass L
    Am J Physiol; 1983 Jun; 244(6):G583-9. PubMed ID: 6859266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian analysis of capillary heterogeneity in the intact pig liver.
    Robinson PJ; Pettitt AN; Zornig J; Bass L
    Biometrics; 1983 Mar; 39(1):61-9. PubMed ID: 6871363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of protein binding determine rates of uptake of drugs by brain.
    Robinson PJ; Rapoport SI
    Am J Physiol; 1986 Dec; 251(6 Pt 2):R1212-20. PubMed ID: 3789202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):289-308. PubMed ID: 3783448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates and implications of co-operativity for enzyme kinetics in the intact liver: method of flow invariants.
    Bass L
    J Theor Biol; 1983 Jan; 100(1):113-21. PubMed ID: 6834856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of capillary heterogeneity on rates of steady uptake of substances by the intact liver.
    Bass L; Ribinson PJ
    Microvasc Res; 1981 Jul; 22(1):43-57. PubMed ID: 7278700
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug administration in hepatic disease.
    Williams RL
    N Engl J Med; 1983 Dec; 309(26):1616-22. PubMed ID: 6358891
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of drug disposition: hemodynamic considerations.
    Wilkinson GR
    Annu Rev Pharmacol; 1975; 15():11-27. PubMed ID: 1096786
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of diffusional barriers on drug and metabolite kinetics.
    de Lannoy IA; Pang KS
    Drug Metab Dispos; 1987; 15(1):51-8. PubMed ID: 2881759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.
    Wagner JG; Szpunar GJ; Ferry JJ
    Drug Metab Dispos; 1984; 12(4):385-8. PubMed ID: 6148202
    [No Abstract]   [Full Text] [Related]  

  • 12. An integrated approach to model hepatic drug clearance.
    Liu L; Pang KS
    Eur J Pharm Sci; 2006 Nov; 29(3-4):215-30. PubMed ID: 16806855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-tissue exchange in liver and heart: the influence of heterogeneity of capillary transit times.
    Goresky CA; Rose CP
    Fed Proc; 1977 Nov; 36(12):2629-34. PubMed ID: 913622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An added complication in the estimation of apparent hepatic blood flow in vivo by pharmacokinetic parameters.
    Stella VJ; Yamaoka K; Levy RH
    Drug Metab Dispos; 1981; 9(2):172-3. PubMed ID: 6113120
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic transport kinetics: effect of anatomic and metabolic heterogeneity on estimates of the average transfer coefficients.
    Forker EL; Luxon BA
    Am J Physiol; 1982 Dec; 243(6):G532-40. PubMed ID: 7149034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and anatomic heterogeneity in the liver acinus: impact on transport.
    Gumucio JJ
    Am J Physiol; 1983 Jun; 244(6):G578-82. PubMed ID: 6859265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake in the liver: the nature of the process.
    Goresky CA
    Int Rev Physiol; 1980; 21():65-101. PubMed ID: 6993399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of marker drugs to measure organ function: a theoretical interpretation.
    Cobby J; Makoid MC
    Eur J Clin Pharmacol; 1980 Nov; 18(6):511-6. PubMed ID: 7461018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic galactose elimination kinetics in the intact pig.
    Keiding S; Johansen S; Winkler K
    Scand J Clin Lab Invest; 1982 May; 42(3):253-9. PubMed ID: 7134810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.